Newsfile Corp
20 Nov 2026, 02:30 UTC · 54m ago
ROSEN, A LEADING NATIONAL FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
Impact · against what's priced in
The notice regarding the lead plaintiff deadline for the Tenax Therapeutics class action is a marginal catalyst. While the lawsuit itself is likely known, the December 28 deadline creates a specific window for increased legal activity and potential settlement pressure.
- TENX−0.20
No priced-in read yet





